An Innovative Health Services & Translational Eye Research Program For Australians Living With Eye Diseases
Funder
National Health and Medical Research Council
Funding Amount
$256,801.00
Summary
My research is focused on the prevention; treatment; and improvement in the quality of life of people with eye diseases, in particular those with diabetic retinopathy (DR), the most common complication of diabetes and a blinding eye condition. My work focuses on three main areas: (a) determining the effectiveness of interventions to prevent and treat DR; (b) evaluating new therapies and biomarkers for DR; (c) evaluating patient-centred, clinical, and economic effectiveness of new treatments for ....My research is focused on the prevention; treatment; and improvement in the quality of life of people with eye diseases, in particular those with diabetic retinopathy (DR), the most common complication of diabetes and a blinding eye condition. My work focuses on three main areas: (a) determining the effectiveness of interventions to prevent and treat DR; (b) evaluating new therapies and biomarkers for DR; (c) evaluating patient-centred, clinical, and economic effectiveness of new treatments for other eye diseases.Read moreRead less
I am a clinical health researcher who combines the principles of public health and multidisciplinary research (from the “platelet to population”) in order to: 1. Identify key issues arising from an evolving epidemic of cardiovascular disease within our ag
I am a cancer epidemiologist, specialising in molecular epidemiology. I investigate the genetic and environmental causes of gynaecological cancers, and their consequences (prognosis, survival, quality of life, economic).
I conduct epidemiological research on illicit drug use and harm, with a particular focus upon surveillance of drug use disorders and morbidity in sentinel populations. My epidemiological research has focused particularly on the comorbidity between drug de
I am a medical oncologist and tumour immunologist, dedicated to basic and translational clinical research particularly in the field of urological cancer and also in melanoma.